Arcturus Therapeutics
ARCT
ARCT
50 hedge funds and large institutions have $50.1M invested in Arcturus Therapeutics in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
2.24% less ownership
Funds ownership: 32.32% → 30.08% (-2.2%)
47% less call options, than puts
Call options by funds: $458K | Put options by funds: $871K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
50
Holding in Top 10
1
Calls
$458K
Puts
$871K
Top Buyers
| 1 | +$1.19M | |
| 2 | +$867K | |
| 3 | +$736K | |
| 4 |
Two Sigma Investments
New York
|
+$661K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$641K |
Top Sellers
| 1 | -$4.54M | |
| 2 | -$1.28M | |
| 3 | -$629K | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$227K |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$195K |